13F HOLDINGS REPORT
Saturn V Capital Management LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001964437-23-000007
Total Value
$238.9M
Positions
20
Other Managers
0
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,126,579 | $33.5M | 14.02% |
| 2 | KALVISTA PHARMACEUTICALS INC | KALV | 1,810,246 | $17.4M | 7.30% |
| 3 | COGENT BIOSCIENCES INC | COGT | 1,775,415 | $17.3M | 7.25% |
| 4 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,124,459 | $16.8M | 7.02% |
| 5 | BIOGEN INC | BIIB | 64,676 | $16.6M | 6.96% |
| 6 | AMYLYX PHARMACEUTICALS INC | AMLX | 886,143 | $16.2M | 6.79% |
| 7 | CYTOKINETICS INC | CYTK | 495,168 | $14.6M | 6.11% |
| 8 | SAREPTA THERAPEUTICS INC | SRPT | 118,401 | $14.4M | 6.01% |
| 9 | HORIZON THERAPEUTICS PUB L | G46188101 | 111,045 | $12.8M | 5.38% |
| 10 | SYNDAX PHARMACEUTICALS INC | SNDX | 807,969 | $11.7M | 4.91% |
| 11 | ITEOS THERAPEUTICS INC | 46565G104 | 994,756 | $10.9M | 4.56% |
| 12 | ASCENDIS PHARMA A/S | ASND | 112,473 | $10.5M | 4.41% |
| 13 | ANAPTYSBIO INC | ANABV | 577,101 | $10.4M | 4.34% |
| 14 | BIOMARIN PHARMACEUTICAL INC | BMRN | 109,685 | $9.7M | 4.06% |
| 15 | ASTRIA THERAPEUTICS INC | 04635X102 | 1,219,093 | $9.1M | 3.81% |
| 16 | BIOCRYST PHARMACEUTICALS INC | BCRX | 982,458 | $7.0M | 2.91% |
| 17 | ARGENX SE | ARGX | 10,074 | $5.0M | 2.07% |
| 18 | MORPHIC HLDG INC | 61775R105 | 136,743 | $3.1M | 1.31% |
| 19 | JASPER THERAPEUTICS INC | JSPRW | 1,387,015 | $970,910 | 0.41% |
| 20 | MERUS N V | N5749R100 | 40,066 | $944,756 | 0.40% |